Moderna Stock Plummets As Third-Quarter Covid Vaccine Sales Disappoint

Moderna stock plummeted early Thursday after the biotech company reported adjusted income of $7.70 per share on $4.97 billion in third-quarter sales.
XOn average, analysts polled by FactSet expected…
Read More